[1] Tonnetti L, Spaccapelo R, Cenci E, et al. Interleukin 4 and 10 exacerbate candidiasis in mice. Eur J Immunol, 1995,25:1559-1565. [2] Cenci E, Romani L, Mencacci A, et al. Interleukin 4 and interleukin 10 inhibit nitric oxide dependent macrophage killing of Candida albicans. Eur J Immunol, 1993,23:1034-1038. [3] Roilides E, Kadiltsoglou I, Dimitriadou A, et al. Interleukin 4 suppresses antifungal activity of human mononuclear phagocytes against Candida albicans in association with decreased uptake of blastoconidia. FEMS Immunol Med Microbiol, 1997,19:169-180. [4] Romani L,Mencacci A,Cenci E,et al. CD4+ subset expression in murine candidiasis:Th responses correlate directly with genetically determined susceptibility or vaccine induced resistance. J Immunol,1993,150:925-931. [5] Talluri G, Marella VK, Shirazian D, et al. Immune response in patients with persistent candiduria and occult candidemia. J Urol, 1999,162:1361-1364. [6] Hachisuka H, Sasai Y. Development of experimental sporotrichosis in normal and modified animals. Mycopathologia, 1981,76:79-82. [7] Kawakami K, Tohyama M, Qifeng X, et al. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans:effects of interleukin 12. Infect Immun,1997,65:1307-1312. [8] Mencacci A, Del Sero GD, Cenci E, et al. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med,1998,187:307-317. |